5-132312242-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_003059.3(SLC22A4):c.475G>A(p.Val159Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000955 in 1,612,888 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_003059.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
SLC22A4 | NM_003059.3 | c.475G>A | p.Val159Met | missense_variant | 2/10 | ENST00000200652.4 | |
MIR3936HG | NR_110997.1 | n.836C>T | non_coding_transcript_exon_variant | 8/8 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
SLC22A4 | ENST00000200652.4 | c.475G>A | p.Val159Met | missense_variant | 2/10 | 1 | NM_003059.3 | P1 | |
MIR3936HG | ENST00000621103.4 | n.836C>T | non_coding_transcript_exon_variant | 8/8 | 1 | ||||
SLC22A4 | ENST00000491257.1 | n.279G>A | non_coding_transcript_exon_variant | 2/4 | 4 | ||||
MIR3936HG | ENST00000669845.1 | n.462C>T | non_coding_transcript_exon_variant | 4/4 |
Frequencies
GnomAD3 genomes AF: 0.000427 AC: 65AN: 152136Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000179 AC: 45AN: 251406Hom.: 0 AF XY: 0.000140 AC XY: 19AN XY: 135874
GnomAD4 exome AF: 0.0000609 AC: 89AN: 1460752Hom.: 0 Cov.: 29 AF XY: 0.0000564 AC XY: 41AN XY: 726778
GnomAD4 genome AF: 0.000427 AC: 65AN: 152136Hom.: 0 Cov.: 33 AF XY: 0.000431 AC XY: 32AN XY: 74320
ClinVar
Submissions by phenotype
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jul 17, 2023 | This sequence change replaces valine, which is neutral and non-polar, with methionine, which is neutral and non-polar, at codon 159 of the SLC22A4 protein (p.Val159Met). This variant is present in population databases (rs11568509, gnomAD 0.2%), and has an allele count higher than expected for a pathogenic variant. This variant has not been reported in the literature in individuals affected with SLC22A4-related conditions. ClinVar contains an entry for this variant (Variation ID: 1392315). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt SLC22A4 protein function. Experimental studies have shown that this missense change does not substantially affect SLC22A4 function (PMID: 17700366). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at